Literature DB >> 28547823

Asthma, other atopic conditions and risk of infections in 105 519 general population never and ever smokers.

J Helby1,2,3, B G Nordestgaard1,2,3,4, T Benfield3,5, S E Bojesen1,2,3,4.   

Abstract

BACKGROUND: Individuals with atopic conditions may have increased susceptibility to infections outside the organs directly affected by their atopic condition.
OBJECTIVE: We tested the hypothesis that atopic conditions overall, and stratified by smoking history, are associated with increased risk of hospitalization for infections.
METHODS: We collected information on smoking history and self-reported atopic conditions from 105 519 individuals from the general population and followed them for up to 23 years for infectious disease hospitalizations and deaths. For asthma, we focused on never smokers with asthma diagnosed before age 50 (early asthma) to minimize confounding by chronic obstructive pulmonary disease.
RESULTS: During follow-up, 11 160 individuals had infections. Never smokers with early asthma versus no atopic conditions had significantly increased risks of any infection (hazard ratio 1.65; 95% confidence interval 1.40-1.94), pneumonia (2.44; 1.92-3.11) and any non-respiratory tract infection (1.36; 1.11-1.67); results were similar in ever smokers. Never smokers with any asthma had significantly increased risks of any infection (1.44; 1.24-1.66) and pneumonia (1.99; 1.62-2.44). Neither atopic dermatitis (1.00; 0.91-1.10) nor hay fever (1.00; 0.93-1.07) was associated with risk of any infection. In never smokers, risk estimates for any infection were comparable between asthma and diabetes, as were the population attributable fractions of 2.2% for any asthma and 2.9% for diabetes.
CONCLUSION: Early asthma was associated with significantly increased risks of any infection, pneumonia and any non-respiratory tract infection in never and ever smokers. In never smokers, risk estimates as well as population attributable fractions for any infection were comparable between asthma and diabetes, suggesting that asthma may be a substantial risk factor for infections in the general population.
© 2017 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  allergy; asthma; epidemiology; infectious disease

Mesh:

Year:  2017        PMID: 28547823     DOI: 10.1111/joim.12635

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

1.  Heterogeneity of asthma and the risk of celiac disease in children.

Authors:  Bhavisha Patel; Chung-Il Wi; M Earth Hasassri; Rohit Divekar; Imad Absah; Eyad Almallouhi; Euijung Ryu; Katherine King; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2018-01-01       Impact factor: 2.587

Review 2.  Epidemiology of Infections and Development of Asthma.

Authors:  Jenny Resiliac; Mitchell H Grayson
Journal:  Immunol Allergy Clin North Am       Date:  2019-04-30       Impact factor: 3.479

3.  Disease Control, Not Severity, Drives Job Absenteeism in Young Adults with Asthma - A Nationwide Cohort Study.

Authors:  Kjell Erik Julius Håkansson; Vibeke Backer; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2022-06-20

4.  Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study.

Authors:  Marios Rossides; Susanna Kullberg; Anders Eklund; Daniela Di Giuseppe; Johan Grunewald; Johan Askling; Elizabeth V Arkema
Journal:  Eur Respir J       Date:  2020-09-03       Impact factor: 16.671

5.  Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia.

Authors:  Emil Ekbom; Jennifer Quint; Linus Schöler; Andrei Malinovschi; Karl Franklin; Mathias Holm; Kjell Torén; Eva Lindberg; Deborah Jarvis; Christer Janson
Journal:  BMC Pulm Med       Date:  2019-12-19       Impact factor: 3.317

6.  Establishing an expert consensus for the operational definitions of asthma-associated infectious and inflammatory multimorbidities for computational algorithms through a modified Delphi technique.

Authors:  Jungwon Yoon; Heather Billings; Chung-Il Wi; Elissa Hall; Sunghwan Sohn; Jung Hyun Kwon; Euijung Ryu; Pragya Shrestha; Hongfang Liu; Young J Juhn
Journal:  BMC Med Inform Decis Mak       Date:  2021-11-08       Impact factor: 2.796

7.  Molecular characterization of pulmonary defenses against bacterial invasion in allergic asthma: The role of Foxa2 in regulation of β-defensin 1.

Authors:  Chuanqi Wei; Xiaoju Tang; Faping Wang; Yan Li; Lin Sun; Fengming Luo
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.